Pathogenicity of exopolysaccharide-producing Actinomyces oris isolated from an apical abscess lesion

International Endodontic Journal

Volumn 46, Issue 2, 2013, Pages 145-154

  Yamane, K ^a   Nambu, T ^a   Yamanaka, T ^a   Ishihara, K ^a   Tatami, T ^a   Mashimo, C ^a   Walker, C B ^b   Leung, K P ^c   Fukushima, H ^a  

^a OSAKA DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^c US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

Actinomyces oris; Apical abscess; Biofilm; Exopolysaccharide

Indexed keywords

BACTERIAL POLYSACCHARIDE;

ACTINOMYCES; ACTINOMYCETALES INFECTION; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOFILM; CLASSIFICATION; CULTURE MEDIUM; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MOUSE; PATHOGENICITY; PHYLOGENY; SPECIES DIFFERENCE; TOOTH PERIAPICAL DISEASE; VIRULENCE; VISCOSITY;

ACTINOMYCES; ACTINOMYCETALES INFECTIONS; ANIMALS; BIOFILMS; CULTURE MEDIA; MALE; MICE; MICE, INBRED BALB C; PERIAPICAL ABSCESS; PHYLOGENY; POLYSACCHARIDES, BACTERIAL; SPECIES SPECIFICITY; VIRULENCE; VISCOSITY;

EID: 84872197255     PISSN: 01432885     EISSN: 13652591     Source Type: Journal    
DOI: 10.1111/j.1365-2591.2012.02099.x     Document Type: Article

References (55)

1. Anriany YA, Weiner RM, Johnson JA, De Rezende CE, Joseph SW (2001) Salmonella enterica serovar Typhimurium DT104 displays a rugose phenotype. Applied and Environmental Microbiology 67, 4048-56.
2. Apothéloz C, Regamey C (1996) Disseminated infection due to Actinomyces meyeri: case report and review. Clinical Infectious Diseases 22, 621-5.
3. Bolton RW, Dyer JK (1986) Human complement activation by purified Capnocytophaga exopolysaccharide. Measurement by radioimmunoassay. Journal of Periodontal Research 21, 634-9.
4. Bolton RW, Dyer JK (1983) Suppression of murine lymphocyte mitogen responses by exopolysaccharide from Capnocytophaga ochracea. Infection and Immunity 39, 476-9.
5. Campbell JH, Pappenheimer AM Jr (1966) Quantitative studies of the specificity of anti-pneumococcal polysaccharide antibodies, types III and VIII-I isolation of oligosaccharides from acid and from enzymatic hydrolysates of S3 and S8. Immunochemistry 3, 195-212.
6. Carrillo M, Valdez B, Vargas L, et al. (2010) In vitro Actinomyces israelii biofilm development on IUD copper surfaces. Contraception 81, 261-4.
7. Collins MD, Hoyles L, Kalfas S, et al. (2000) Characterization of Actinomyces isolates from infected root canals of teeth: description of Actinomyces radicidentis sp. nov. Journal of Clinical Microbiology 38, 3399-403.
8. Costerton JW, Cheng K-J, Geesey GG, et al. (1987) Bacterial biofilms in nature and disease. Annual Review of Microbiology 41, 435-64.
9. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 21, 1318-22.
10. Davies D (2003) Understanding biofilm resistance to antibacterial agents. Nature Reviews. Drug Discovery 2, 114-22.
11. Do T, Henssge U, Gilbert SC, Clark D, Beighton D (2008) Evidence for recombination between a sialidase (nanH) of Actinomyces naeslundii and Actinomyces oris, previously named 'Actinomyces naeslundii genospecies 1 and 2'. FEMS Microbiology Letters 288, 156-62.
12. Diaz PI, Chalmers NI, Rickard AH, et al. (2006) Molecular characterization of subject-specific oral microflora during initial colonization of enamel. Applied and Environmental Microbiology 72, 2837-48.
13. Dubey GP, Ben-Yehuda S (2011) Intercellular nanotubes mediate bacterial communication. Cell 144, 590-600.
14. Dueholm MS, Petersen SV, Sønderkær M, et al. (2010) Functional amyloid in Pseudomonas. Molecular Microbiology 77, 1009-20.
15. Dyer JK, Bolton RW (1985) Purification and chemical characterization of an exopolysaccharide isolated from Capnocytophaga ochracea. Canadian Journal of Microbiology 31, 1-5.
16. Ellen RP (1976) Establishment and distribution of Actinomyces viscosus and Actinomyces naeslundii in the human oral cavity. Infection and Immunity 14, 1119-24.
17. Figdor D, Sjögren U, Sörlin S, Sundqvist G, Nair PNR (1992) Pathogenicity of Actinomyces israelii and Arachnia propionica: experimental infection in guinea pigs and phagocytosis and intraceilular killing by human polymorphonuclear leukocytes in vitro. Oral Microbiology and Immunology 7, 129-36.
18. Fukushima H, Moroi H, Inoue J, et al. (1992) Phenotypic characteristics and DNA relatedness in Prevotella intermedia and similar organisms. Oral Microbiology and Immunology 7, 60-4.
19. Fukushima H, Yamamoto K, Hirohata K, Sagawa H, Leung K-P, Walker CB (1990) Localization and identification of root canal bacteria in clinically asymptomatic periapical pathosis. Journal of Endodontics 16, 534-8.
20. Tang G, Yip H-K, Samaranayake LP, Chan K-Y, Luo G, Fang HHP (2004) Direct detection of cell surface interactive forces of sessile, fimbriated and non-fimbriated Actinomyces spp. using atomic force microscopy. Archives of Oral Biology 49, 727-38.
21. Happonen R-P, Söderling E, Viander M, Linko-Kettunen L, Pelliniemi LJ (1985) Immunocytochemical demonstration of Actinomyces species and Arachnia propionica in periapical infections. Journal of Oral Pathology 14, 405-13.
22. Henssge U, Do T, Radford DR, Gilbert SC, Clark D, Beighton D (2009) Emended description of Actinomyces naeslundii and descriptions of Actinomyces oris sp. nov. and Actinomyces johnsonii sp. nov., previously identified as Actinomyces naeslundii genospecies 1, 2 and WVA 963. International Journal of Systematic and Evolutionary Microbiology 59, 509-16.
23. Kalfas S, Figdor D, Endo D, Sundqvist G (2001) A new bacterial species associated with failed endodontic treatment: identification and description of Actinomyces radicidentis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 92, 208-14.
24. Katoh K, Toh H (2010) Parallelization of the MAFFT multiple sequence alignment program. Bioinformatics 26, 1899-900.
25. Kobayashi H (1995) Airway biofilm disease: clinical manifestations and therapeutic possibilities using macrolides. Journal of Infectious Chemotherapy 1, 1-15.
26. Kolenbrander PE, Egland PG, Diaz PI, Palmer RJ Jr (2005) Genome-genome interactions: bacterial communities in initial dental plaque. Trends in Microbiology 13, 11-5.
27. Latasa C, Solano C, Penadés JR, Lasa I (2006) Biofilm-associated proteins. Comptes Rendus Biologies 329, 849-57.
28. Liaudet L, Erard P, Kaeser P (1996) Cutaneous and muscular abscesses secondary to Actinomyces meyeri pneumonia. Clinical Infectious Diseases 22, 185-6.
29. Mishra A, Wu C, Yang J, Cisar JO, Das A, Ton-That H (2010) The Actinomyces oris type 2 fimbrial shaft FimA mediates co-aggregation with oral streptococci, adherence to red blood cells and biofilm development. Molecular Microbiology 77, 841-54.
30. Nair PNR (2006) On the causes of persistent apical periodontitis: a review. International Endodontic Journal 39, 249-81.
31. Nair PNR, Brundin M, Sundqvist G, Sjögren U (2008) Building biofilms in vital host tissues: a survival strategy of Actinomyces radicidentis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology 106, 595-603.
32. Nair PNR, Schroeder HE (1984) Periapical actinomycosis. Journal of Endodontics 10, 567-70.
33. Nyvad B, Kilian M (1987) Microbiology of the early colonization of human enamel and root surfaces in vivo. Scandinavian Journal of Dental Research 95, 369-80.
34. O'Toole GA, Gibbs KA, Hager PW, Phibbs PV Jr, Kolter R (2000) The global carbon metabolism regulator Crc is a component of a signal transduction pathway required for biofilm development by Pseudomonas aeruginosa. Journal of Bacteriology 182, 425-31.
35. Paddick JS, Brailsford SR, Kidd EAM, Beighton D (2005) Phenotypic and genotypic selection of microbiota surviving under dental restorations. Applied and Environmental Microbiology 71, 2467-72.
36. Rocha CT, Rossi MA, Leonardo MR, Rocha LB, Nelson-Filho P, Silva LAB (2008) Biofilm on the apical region of roots in primary teeth with vital and necrotic pulps with or without radiographically evident apical pathosis. International Endodontic Journal 41, 664-9.
37. Ruhl S, Cisar JO, Sandberg AL (2000) Identification of polymorphonuclear leukocyte and HL-60 cell receptors for adhesins of Streptococcus gordonii and Actinomyces naeslundii. Infection and Immunity 68, 6346-54.
38. Ryder C, Byrd M, Wozniak DJ (2007) Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Current Opinion in Microbiology 10, 644-8.
39. Schwarzmann S, Boring JR III (1971) Antiphagocytic effect of slime from a mucoid strain of Pseudomonas aeruginosa. Infection and Immunity 3, 762-7.
40. Shankar S, Ye RW, Schlictman D, Chakrabarty AM (1995) Exopolysaccharide alginate synthesis in Pseudomonas aeruginosa: enzymology and regulation of gene expression. Advances in Enzymology and Related Areas of Molecular Biology 70, 221-55.
41. Siqueira JF Jr, Rôças IN (2008) Clinical implications and microbiology of bacterial persistence after treatment procedures. Journal of Endodontics 34, 1291-301.
42. Sumita M, Hoshino E, Iwakul M (1998) Experimental actinomycosis in mice induced by alginate gel particles containing Actinomyces israelii. Endodontics and Dental Traumatology 14, 137-43.
43. Sunde PT, Olsen I, Debelian GJ, Tronstad L (2002) Microbiota of periapical lesions refractory to endodontic therapy. Journal of Endodontics 28, 304-10.
44. Sundqvist G, Reuterving C-O (1980) Isolation of Actinomyces israelii from periapical lesion. Journal of Endodontics 6, 602-6.
45. Tanner A, Maiden MFJ, Paster BJ, Dewhirst FE (1994) The impact of 16S ribosomal RNA-based phylogeny on the taxonomy of oral bacteria. Periodontology 2000 5, 26-51.
46. Vuong C, Kocianova S, Voyich JM, et al. (2004) A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. The Journal of Biological Chemistry 279, 54881-6.
47. Wai SN, Mizunoe Y, Takade A, Kawabata S-I, Yoshida S-I (1998) Vibrio cholerae O1 strain TSI-4 produces the exopolysaccharide materials that determine colony morphology, stress resistance, and biofilm formation. Applied and Environmental Microbiology 64, 3648-55.
48. Wu J, Xi C (2009) Evaluation of different methods for extracting extracellular DNA from the biofilm matrix. Applied and Environmental Microbiology 75, 5390-5.
49. Yamanaka T, Furukawa T, Matsumoto-Mashimo C, et al. (2009) Gene expression profile and pathogenicity of biofilm-forming Prevotella intermedia strain 17. BMC Microbiology 11, 1-15.
50. Yamanaka T, Sumita-Sasazaki Y, Sugimori C, et al. (2010) Biofilm-like structures and pathogenicity of Escherichia hermannii YS-11, a clinical isolate from a persistent apical periodontitis lesion. FEMS Immunology and Medical Microbiology 59, 456-65.
51. Yamane K, Nambu T, Yamanaka T, et al. (2010) Complete genome sequence of Rothia mucilaginosa DY-18: a clinical isolate with dense meshwork-like structures from a persistent apical periodontitis lesion. Sequencing 2010, 1-6.
52. Yamane K, Ogawa K, Yoshida M, et al. (2009) Identification and characterization of clinically isolated biofilm-forming gram-positive rods from teeth associated with persistent apical periodontitis. Journal of Endodontics 35, 347-52.
53. Yamane K, Yamanaka T, Yamamoto N, et al. (2005) A novel exopolysaccharide from a clinical isolate of Prevotella nigrescens: purification, chemical characterization and possible role in modifying human leukocyte phagocytosis. Oral Microbiology and Immunology 20, 1-9.
54. Yasuda H, Koga T, Fukuoka T (1999) In vitro and in vivo models of bacterial biofilms. Methods in Enzymology 310, 577-95.
55. Yeung MK (1999) Molecular and genetic analyses of Actinomyces spp. Critical Reviews in Oral Biology and Medicine 10, 120-38.